Physician profile
Gregory Benedict
NPI 1962816488
$3,317.06
in general payments reported to CMS, 2019-2025
17 companies · $485 in 2025
The $485 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,009 · 2020: $196 · 2021: $446 · 2022: $467 · 2023: $113 · 2024: $601 · 2025: $485.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,198.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,640.49 | 2019-2025 | Eterna, Proclaim |
| Nevro Corp. | $435.34 | 2020-2024 | Senza |
| Medtronic USA, INC. | $249.84 | 2019 | |
| Medtronic, INC. | $203.67 | 2021-2024 | Intellis Adaptivestim |
| Si-Bone, INC. | $154.18 | 2025 | |
| Globus Medical, INC. | $131.67 | 2025 | Senza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $108.96 | 2023-2024 | Relistor |
| Vertos Medical, INC. | $107.94 | 2024 | Mild Device Kit |
| Vertex Pharmaceuticals Incorporated | $85.16 | 2024-2025 | |
| Boston Scientific Corporation | $43.45 | 2025 | General - Pain Management |
| Stryker Corporation | $38.21 | 2025 | Mild Device Kit |
| Depuy Synthes Sales INC. | $30.06 | 2023 | Monovisc |
| Nalu Medical, INC. | $26.09 | 2025 | Nalu Neurostimulation System |
| Biodelivery Sciences International, INC. | $20.35 | 2021 | |
| Curonix LLC | $14.60 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $14.44 | 2025 | Belbuca |
| Avanos Medical | $12.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Benedict listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.